Related Experiment Video
Updated: Jan 8, 2026
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
15.1K
Burgeoning Non-Muscle Invasive Bladder Cancer Space: AUA 2025 Clinical Trials Presented (Doctor/Patient Podcast)
Rick Bangs1,2, Roger Li3
1Bladder Cancer Patient Advocate, Pittsford, NY, USA. chezrick2@gmail.com.
Oncology and Therapy
|December 15, 2025
Summary
New bladder cancer treatments are emerging, offering hope for patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC). These advancements, discussed at AUA 2025, include novel therapies and quality of life comparisons, aiding informed patient-physician decisions.
Area of Science:
- Urology
- Oncology
- Medical Research
Background:
- High-risk non-muscle invasive bladder cancer (HR-NMIBC) presents significant treatment challenges.
- Current standard of care involves bacillus Calmette-Guérin (BCG) therapy, with limited options for BCG-naïve or unresponsive cases.
Purpose of the Study:
- To review key findings from the American Urological Association (AUA) 2025 Annual Meeting concerning bladder cancer.
- To simplify complex data for a broader audience, including patients and non-specialists, to facilitate informed treatment decisions.
Main Methods:
- Discussion of four clinical trials focused on BCG-naïve and BCG-unresponsive HR-NMIBC.
- Review of novel treatment approaches including PD-1 inhibitors with BCG, intravesical drug delivery systems, and oncolytic therapies.
- Analysis of a prospective observational trial comparing quality of life outcomes for bladder preservation versus radical cystectomy.
Main Results:
- Emerging treatments show promise in survival and disease progression for HR-NMIBC.
- Novel therapies offer potential for convenient, accessible treatment with comparable or improved efficacy and safety profiles.
- Bladder preservation strategies may offer different quality of life outcomes compared to radical cystectomy.
Conclusions:
- The AUA 2025 meeting highlights a growing number of treatment options for HR-NMIBC.
- New agents and expanded uses for existing therapies offer improved possibilities for patients.
- Shared decision-making and nuanced discussions regarding bladder preservation are crucial for optimal patient care.
Related Concept Videos
01:30Urinary Tract Calculi III: Medical Management
174
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
174
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
349
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
349
01:19Anatomy of the Genitourinary System II: Bladder and Urethra
1.2K
The lower urinary system consists of the urinary bladder and urethra, which are essential in storing and expelling urine from the body. Together with the internal and external sphincters, these structures work together to regulate urination effectively.Anatomy of the BladderThe urinary bladder is a muscular, stretchable organ behind the pubic bone and in front of the rectum. In females, the bladder is positioned anterior to the vagina and inferior to the uterus, while in males, it is located...
1.2K
01:23Urinary Bladder
3.0K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
3.0K
01:25Urinary Tract Calculi VI: Surgical Management
331
Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
331
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
230
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
230